Live feed
Filing
SC 13G/A
SC 13G/A0001437749-17-011718·PLx Pharma Inc.
Schedule 13G ownership disclosure
DIPEXIUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25456J104
Event date: 2017-06-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-17-011718
- Form type
- SC 13G/A
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- Jun 22, 2017
- Reporting period
- Jun 14, 2017
- Description
- Schedule 13G beneficial ownership